Research on PMS dates back to the late 20th century, when Dr. Charles N. Serhan first discovered that the resolution of inflammation is not a passive process, but actively mediated by lipid-derived bioactive molecules. This observation revolutionized modern immunology and gave rise to a new paradigm in inflammation management.

Dr. Serhan's team successfully isolated, structured, and synthesized several subfamilies of SPMs, and experimentally demonstrated that these molecules not only suppress inflammation and pain, but also reprogram the immune response to facilitate tissue repair. This line of research was subsequently expanded by other renowned scientists such as Dr. Bruce Levy, Dr. Jessmond Dalli, Dr. Jan Schwab, and Dr. Dipak Panigrahy, among others, whose contributions continue to expand our understanding of the effects of SPMs on various health conditions, such as pulmonary, neurological, and oncological diseases.

In this context, Solutex – as the parent company of Azur – has been a strategic partner in the industrial translation of this knowledge, developing Lipinova®, a unique ingredient standardized in active and quantifiable SPMs, representing an effective transition from basic research to clinical and nutritional applications.

As a result of nearly 20 years of research, Solutex has established itself as a pioneer in the science and technology of SPMs at a commercial level, being the first to develop - in close collaboration with Dr. Serhan, co-author of our patents and director of our Scientific Advisory Board - the only ingredient (Lipinova®) worldwide standardized in these SPMs lipid mediators and demonstrating its effectiveness in inflammatory processes in clinical and scientific studies.

Today, Solutex leads the way in this field with more than 130 international patents, reflecting its innovative capacity and commitment to translational research.

At Azur, dedicated to people's present and future health and well-being, we are committed to providing people with the most advanced science in inflammation management.